The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

At the J.P. Morgan Healthcare Conference, Nvidia announced major AI partnerships with Lilly and Thermo Fisher Scientific to ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up ...

ATLANTA and MISSISSAUGA, ON, May 28, 2025 /PRNewswire/ -- Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and manufacturing ...

The MarketWatch News Department was not involved in the creation of this content. -- Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...

The Forum on Neuroscience and Nervous System Disorders hosted a public workshop on June 21-22, 2010, bringing together key stakeholders, to present promising current and emerging technologies with ...

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery ™ System, has announced a collaboration with Cytiva, a global life sciences ...